Table 1.
Patient characteristics
| Variables, median (range) | All n = 80 | Male n = 51 | Female n = 29 | P |
|---|---|---|---|---|
| Patient characteristics | ||||
| Median age (years) | 66 (28–82) | 67 (28–82) | 64 (29–76) | 0.289 |
| Percentage with ASA 3/4 | 53.9 | 51.1 | 58.6 | 0.521 |
| Patients with PVE (%) | 34 (42.5) | 19 (37.3) | 15 (51.7) | 0.208 |
| Weight (kg) | 80 (47–134) | 82 (52-109) | 72 (47–134) | 0.032 |
| Height (cm) | 174 (155–205) | 176 (160–205) | 165 (155–180) | <0.001 |
| BMI (kg/m2) | 24.9 (18.7–46.4) | 24.6 (20.2–37.7) | 27.3 (18.7–46.4) | 0.837 |
| BMI >30 kg/m2 (%) | 14 (17.5) | 5 (9.8) | 9 (31.0) | 0.016 |
| Child–Pugh grade | ||||
| Percentage with A | 82.1 | 83.7 | 79.3 | 0.627 |
| Percentage with B | 17.9 | 16.3 | 20.7 | 0.627 |
| MELD score | 7 (6–20) | 7 (6–20) | 7 (6–19) | 0.758 |
| Indication (%) | ||||
| Colorectal liver metastases | 24 (30.0) | 15 (29.4) | 9 (31.0) | 0.879 |
| Other metastases | 6 (7.5) | 3 (5.9) | 3 (10.3) | — |
| Hepatocellular carcinoma | 15 (18.8) | 14 (27.5) | 1 (3.4) | 0.008 |
| Cholangiocarcinoma | 28 (35.0) | 16 (31.4) | 12 (41.4) | 0.367 |
| Gallbladder carcinoma | 1 (1.3) | 0 (0.0) | 1 (3.4) | — |
| Benign lesion | 5 (6.3) | 2 (3.9) | 3 (10.3) | — |
| Living donor liver transplant | 1 (1.3) | 1 (2.0) | 0 (0.0) | — |
ASA, American society of anesthesiologists; PVE, portal vein embolization; BMI, body mass index.